Eradivir Secures $10.25M for Influenza Study
Biotech firm Eradivir raises $10.25M for Phase 2a EV25 study, aiming to revolutionize influenza treatment.
- Latest
- Trending
Biotech firm Eradivir raises $10.25M for Phase 2a EV25 study, aiming to revolutionize influenza treatment.
Bitcoin price surges to $66,000; analysts predict further gains. Experts foresee new all-time highs driven by market trends.
Explore the latest trends and signals in the crypto market based on social media insights.
Despite Americans feeling job search woes, economists remain optimistic with signs of a solid but cooling labor market.
Explore the latest in emerging tech, software development, and cybersecurity to stay ahead in the fast-paced digital world.
Discover why Carpenter Technology stock has surged 120%. Learn about its strong fundamentals and institutional backing.
Vitalik Buterin proposes a new alignment strategy to enhance Ethereum's decentralization and security.
Explore the latest market trends and social media insights impacting crypto and investment strategies as of Sep 29, 2024.
New crypto threat on Google Play Store—learn why crypto wallets are at risk and how to protect your digital assets.
Google spent $2.7 billion to rehire AI expert Noam Shazeer through a startup deal, highlighting the fierce AI talent race.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.